Colby Wood
Managing Partner @ Sonder Capital
San Francisco, United States
Colby Wood is a Series A investor at Sonder Capital in San Francisco focused on Diabetes and Health Care. Colby Wood has 25 years of investment experience in both public and private companies with expertise in healthcare and medical devices. He has been actively involved as an investor, asset gatherer, and business development executive for early-stage companies in both the financial services and medical technology sectors. Prior to Sonder Capital, Mr.Wood was a Portfolio Manager and Equity Research Analyst with Oechsle International Advisors in London and Boston where he was responsible for medical technology investments globally. He currently serves on the board of Procept BioRobotics.
Last updated:
For AI agents: llms.txt
Industries Colby Wood invests in
Stages Colby Wood invests in
Countries Colby Wood invests in
Investment Focus
Industry
- Diabetes 1 (0%)
- Health Care 1 (0%)
- Biotechnology 1 (0%)
- Medical Device 1 (0%)
About Sonder Capital
Sonder Capital invests in teams and technologies that can transform healthcare in the medical device, diagnostic and healthtech sectors. We are Foundational Investors – we commit our energy and capital early to guide and support companies from inception to acquisition or IPO. We look for big ideas that will change lives.
Sonder Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andy McGibbon
Managing Partner
|
|||
|
Colby Wood
Managing Partner
|
|||
Jay Watkins
Managing Partner
|
|||
Fred Moll, M.D
Managing Partner
|
|||
Kate Garrett
Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Colby Wood invest in?
Colby Wood invests primarily in Diabetes, Health Care and Biotechnology startups, most often at Series A stage. Most of the 0 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
